Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Aurinia Pharmaceuticals Inc AUPH

Aurinia Pharmaceuticals Inc. is a Canada-based fully integrated biopharmaceutical company. The Company is focused on delivering therapies to treat targeted patient populations with a high unmet medical need that are impacted by autoimmune, kidney and rare diseases. The Company has developed LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis... see more

NDAQ:AUPH - Post Discussion

Aurinia Pharmaceuticals Inc > WTH ? Happened today ?
View:
Post by TheRainman on Nov 22, 2021 3:19pm

WTH ? Happened today ?

I don't get it  ?
Comment by TimeScape on Nov 22, 2021 3:28pm
Aurinia announced a possible large financing Friday after the close.  Obviously, if they are doing a financing, they aren't going to be bought out.  The price simply dropped back to what it was before the takeover rumours started.  I sold 40% of my position at $33.50.  Still have the other 60%.  Will be interesting to see how rapidly the sales for lupkinis ramp up ...more  
Comment by TheRainman on Nov 22, 2021 4:16pm
I also see there was a shite load of insider sales in November , That is not a good sign.
Comment by jboom70 on Dec 04, 2021 5:59pm
New suitor reported again. Short term price changes are just games with the shorts, they have beat this thing hard and won't let it alone. No matter a BO is a set price. This was designed to sell. Prospectus was to replace old one for good house keeping.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities